• GLP-1 receptor agonists may be 'critical' weight-loss tool in severe pediatric obesity

    1 month ago - By Healio

    NASHVILLE, Tenn. - Adolescents with severe obesity who struggle with weight loss may derive the most benefits from a combination of intensive lifestyle modification and an injectable GLP-1 receptor agonist, according to a speaker here.
    GLP-1 receptor agonists are primarily prescribed for adults with type 2 diabetes for improving glycemic control, with one agent, liraglutide , FDA approved for the treatment of adult obesity, Aaron S. Kelly, PhD, co-director of the Center for Pediatric Obesity Medicine at the University of Minnesota, said during a presentation at
    Read more ...